ID2 and hepatocellular carcinoma: In hepatocellular carcinoma, KIAA1429 increased the m6A level of ID2 (a dominant-negative antagonist of transcription factors) mRNA, which subsequently reduced ID2 expression and promoted cell migration and invasion [14].